Interleukin 17 Receptor A Antagonists [MoA] - N0000193279
Pharmacologic Class Information
| Pharmacologic Code | N0000193279 |
| Pharmacologic Name | Interleukin 17 Receptor A Antagonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Interleukin 17 Receptor A Antagonists
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Interleukin 17 Receptor A Antagonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0187-0004 | Siliq | Non-Proprietary Name: Brodalumab | Injection | Subcutaneous | Bausch Health Us Llc | ACTIVE |